Deerpath Capital Management

About The Fund

Deerpath Capital Management, based in New York, is a specialist cash-flow based senior debt lender catering to lower middle market companies. They offer financial solutions primarily in the form of senior loans, but also engage in equity participation and royalty investments, typically on an opportunistic basis. Deerpath is focused on a range of industries, including business services, healthcare, communications, technology, energy, and manufacturing. They have the expertise to manage investments across multiple sectors, such as BioTech, Medical Devices, DeepTech, Healthcare & Wellness, Investment Management, and more. With a strong presence across the United States, supported by regional offices in Chicago, Ft. Lauderdale, Houston, and Los Angeles, they are adept at crafting creative, tailored funding structures for their investees. Deerpath's investment strategy is characterized by a rigorous and disciplined approach, committed to building long-term relationships with its partners. The fund specializes in various stages of a company's lifecycle, including Seed, Startup, Early Stage, Expansion, and Later Stage investments through MBO/LBO scenarios. Deerpath is dedicated to sustainable investment practices and adheres to Responsible Investment principles, ensuring that ethical considerations are integrated into their investment process. Their team, comprised of over 100 members, has a remarkable track record of more than 1,000 investments and has deployed over $11.0 billion in capital since its founding in 2007. Deerpath's investment range is between $25 million and $125 million per borrower but has the operational flexibility to increase funding for add-on acquisitions as portfolio companies grow. This clear focus on consistency, discipline, and partnership makes Deerpath a reputable and established partner for businesses seeking growth capital within the lower middle market spectrum.